# Constipation in a Patient With Thymoma: A Diagnostic Mimic of Myasthenia Gravis

**Authors:** Nirmeen Maali, Amro Ghanim, Sathyanarayana Gowda

PMC · DOI: 10.7759/cureus.93097 · Cureus · 2025-09-24

## TL;DR

A patient with thymoma initially showed constipation symptoms resembling myasthenia gravis but later developed neurological symptoms that responded to treatment.

## Contribution

Highlights the diagnostic challenge of paraneoplastic myasthenia gravis in thymoma patients with atypical presentations.

## Key findings

- Initial constipation symptoms mimicked myasthenia gravis but lacked positive antibody tests or neuromuscular symptoms.
- Later neurological symptoms emerged and responded to pyridostigmine and corticosteroids despite negative antibodies.
- Emphasizes the importance of considering evolving paraneoplastic syndromes in thymoma patients.

## Abstract

Constipation is a common complaint, but may present atypically in patients with underlying malignancies. We present a 54-year-old man with metastatic thymoma who was admitted with a one-week history of constipation, abdominal discomfort, and nausea. Imaging showed proximal colonic fecal loading with sparing of the descending colon, raising suspicion of dysmotility possibly secondary to a paraneoplastic syndrome. Myasthenia gravis (MG), a known thymoma-associated disorder, was suspected. However, acetylcholine receptor and muscle-specific tyrosine kinase (MuSK) antibodies were negative, and no neuromuscular symptoms were present. The patient responded well to conservative management and was discharged. Two months later, he was readmitted with rapidly progressive bulbar and generalized weakness, severe dysphagia, diplopia, and ptosis, raising renewed concern for MG. Despite persistently negative antibodies, he improved with pyridostigmine and corticosteroids. This case illustrates the evolving nature of paraneoplastic MG, the need to consider both common and rare causes of gastrointestinal symptoms in thymoma patients, and the importance of avoiding premature diagnostic anchoring.

## Linked entities

- **Chemicals:** pyridostigmine (PubChem CID 4991)
- **Diseases:** constipation (MONDO:0002203), thymoma (MONDO:0006456), myasthenia gravis (MONDO:0009688)

## Full-text entities

- **Genes:** MUSK (muscle associated receptor tyrosine kinase) [NCBI Gene 4593] {aka CMS9, FADS}
- **Diseases:** fecal (MESH:D005242), diplopia (MESH:D004172), Thymoma (MESH:D013945), dysmotility (MESH:D015154), MG (MESH:D009157), gastrointestinal symptoms (MESH:D012817), weakness (MESH:D018908), dysphagia (MESH:D003680), abdominal discomfort (MESH:D000007), paraneoplastic syndrome (MESH:D010257), nausea (MESH:D009325), malignancies (MESH:D009369), Constipation (MESH:D003248), ptosis (MESH:C564553), neuromuscular symptoms (MESH:D020879)
- **Chemicals:** pyridostigmine (MESH:D011729)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12551344/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12551344/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12551344/full.md

---
Source: https://tomesphere.com/paper/PMC12551344